N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine recepto

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544328, 544331, 544360, 544363, 544376, 544380, A61K 31495

Patent

active

057030839

ABSTRACT:
Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addidon salts thereof wherein: R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, and R.sub.7 independently represent hydrogen, halogen, hydroxy, alkyl, alkoxy, amino, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, cyano, nitro, trifluoromethyl, or trifluoromethoxy;

REFERENCES:
patent: 5250528 (1993-10-01), Oku et al.
patent: 5364849 (1994-11-01), Cliffe et al.
patent: 5395835 (1995-03-01), Glase et al.
Murray et al., (1995), "A Novel Series of Arylpiperazines with High Affinity and Selectivity for the Dopamine D.sub.3 Receptor," Bioorg. Med. Chem. Let., vol. 5, No. 3, pp. 219-222.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine recepto does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine recepto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine recepto will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-202483

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.